It is a broadly described annual report of The ACME Laboratories Limited in the year of 2013. The Company paid Taka. 1765.80 million to the National Exchequer in the form of corporate Income Tax, and Value Added Tax (VAT) and Import duties for the financial year 2013. During the year ending June 30, 2013, the company has accrued a net profit of BDT. 851,199,356 which after provision of income tax is stood at BDT. 533,520,825. Revenue increased 3.43% in 2012-13 to BDT 9,809 million, compared to BDT 9,484 million, which reflects a nominal growth as a result of sluggish industry growth (9.59%). Gross profit margin at 34.73% has been sustained with an increase in net income ratio at 5.44% over the prior period (5.02%). During the year, the exports amounting BDT 337.53 million as against BDT.195.58 million in the previous year, with 75.69% growth. Net Assets Value per share has reached BDT 65.09 and the Earnings per share (EPS) at BDT 4.35 with an increase of 6.62% over prior year.
The Board of Directors has proposed 30% dividend to the existing shareholders which come to BDT. 466,893,300. It may be noted that the board vides resolution dated June 20, 2013, has paid an amount of BDT. 99,077,750 as interim dividend to the shareholders participated in the private placement as initiated by the company. These financial statements are presented in Bangladesh Taka (Taka/Tk/BDT) which is the company’s functional currency. All financial information presented in Taka has been rounded off to the nearest Taka.
More Annual Report of The ACME Laboratories Limited:
